Precigen (Germany) Top Insiders

I5X Stock  EUR 0.83  0.04  4.60%   
Precigen employs about 456 people. The company is managed by 21 executives with a total tenure of roughly 154 years, averaging almost 7.0 years of service per executive, having 21.71 employees per reported executive. Examination of Precigen's management performance can provide insight into the company performance.
Helen Sabzevari  CEO
President, Chief Executive Officer, President - Precigen, Inc.
Randal Kirk  Chairman
Chairman of the Board, Chief Executive Officer
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Precigen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
For more detail on how to invest in Precigen Stock please use our How to Invest in Precigen guide.

Precigen Management Team Effectiveness

The company has return on total asset (ROA) of (0.1219) % which means that it has lost $0.1219 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.5132) %, meaning that it generated substantial loss on money invested by shareholders. Precigen's management efficiency ratios could be used to measure how well Precigen manages its routine affairs as well as how well it operates its assets and liabilities.

Precigen Workforce Comparison

Precigen is currently regarded as number one stock in number of employees category among its peers. The total workforce of Biotechnology industry is currently estimated at about 21,083. Precigen holds roughly 456 in number of employees claiming about 2.16% of stocks in Biotechnology industry.
The company has Profit Margin (PM) of 0.22 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of (0.52) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.52.

Precigen Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of sixty-one. Precigen Price Series Summation is a cross summation of Precigen price series and its benchmark/peer.

Precigen Notable Stakeholders

A Precigen stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Precigen often face trade-offs trying to please all of them. Precigen's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Precigen's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Thomas ReedFounder, Chief Science OfficerProfile
Helen SabzevariPresident, Chief Executive Officer, President - Precigen, Inc.Profile
Randal KirkChairman of the Board, Chief Executive OfficerProfile
Jeffrey PerezSenior Vice President — Intellectual Property AffairsProfile
Rick SterlingChief Financial OfficerProfile
Steven FrankIndependent DirectorProfile
Jeffrey KindlerIndependent DirectorProfile
Cesar AlvarezIndependent DirectorProfile
Vinita GuptaIndependent DirectorProfile
Fred HassanIndependent DirectorProfile
James TurleyIndependent DirectorProfile
Dean MitchellIndependent DirectorProfile
Robert ShapiroLead Independent DirectorProfile
Rob RussellVP HRProfile
Donald LehrChief Legal OfficerProfile
Rutul ShahChief OfficerProfile
Randal JDEx ChairmanProfile
Helen MPHCEO PresProfile
Steven HarasymVP RelationsProfile
Harry ThomasianChief OfficerProfile
Marie RossiVP CommunicationsProfile

About Precigen Management Performance

The success or failure of an entity such as Precigen often depends on how effective the management is. Precigen management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Precigen management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Precigen management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. Precigen, Inc. was founded in 1998 and is based in Germantown, Maryland. PRECIGEN INC operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. It employs 423 people.

Precigen Workforce Analysis

Traditionally, organizations such as Precigen use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Precigen within its industry.

Precigen Manpower Efficiency

Return on Precigen Manpower

Revenue Per Employee227.8K
Revenue Per Executive4.9M
Net Loss Per Employee202.1K
Net Loss Per Executive4.4M

Complementary Tools for Precigen Stock analysis

When running Precigen's price analysis, check to measure Precigen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Precigen is operating at the current time. Most of Precigen's value examination focuses on studying past and present price action to predict the probability of Precigen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Precigen's price. Additionally, you may evaluate how the addition of Precigen to your portfolios can decrease your overall portfolio volatility.
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges